封面
市場調查報告書
商品編碼
1918373

絲胺酸市場-2026-2031年預測

Phosphatidylserine Market - Forecast from 2026 to 2031

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計絲胺酸市場將從 2025 年的 289,058,000 美元成長到 2031 年的 401,651,000 美元,複合年成長率為 5.64%。

絲胺酸(PS) 是一種磷脂,對細胞膜功能至關重要,在腦組織中的含量尤其高。歷史上,腦病變(BSE) 問題導致牛源性磷脂醯絲胺酸的供應中斷,促使人們轉向植物來源磷脂,主要來源是大豆卵磷脂和向日葵卵磷脂。這種轉變鞏固了人們對更安全、更永續替代品的偏好,使得向日葵來源的磷脂醯絲胺酸因其非基因改造 (non-GMO) 特性而價格更高。目前,磷脂醯絲氨酸市場正擴展至膳食補充劑(片劑、軟膠囊和粉末)以及新興的機能性食品和飲料領域,其核心應用集中在認知支持、壓力調節和運動後恢復等方面。

全球人口老化和人們對認知能力下降的意識提升推動了PS補充劑的需求成長,這些補充劑聲稱可以增強老年人的記憶力和思維能力。此外,PS調節皮質醇的作用也刺激了運動營養領域對PS補充劑的需求,用於幫助年輕人運動後恢復和最佳化認知能力,從而進一步促進了PS市場的成長。

各國的法規結構存在顯著差異。在美國,根據《膳食補充劑健康與教育法案》(DSHEA),FDA批准的健康聲明允許包含詳細的認知功能通訊,並附帶免責聲明,這有利於膳食補充劑領域的積極行銷和大規模普及。相較之下,歐盟的EFSA(歐洲食品安全局)嚴格審查(EC法規1924/2006)不允許發布第13.1條規定的特定聲明,限制了與促進大腦健康相關的明確聲明,從而將產品定位限制在一般健康促進領域。日本的特定保健用途食品(FOSHU)系統則在老齡化社會背景下利用科學證據,促進相關功效快速納入已註冊的機能性食品和膳食補充劑中。

原料價格與主要大豆和葵花籽生產國(美國、巴西、中國)卵磷脂商品價格的波動直接相關,產品則依酵素轉化成本分級。高純度(超過50%)用於高階膳食補充劑,而低濃度則用於食品強化。葵花籽卵磷脂的高價格反映了消費者對潔淨標示產品的需求,但轉化技術的集中(中國和北美)造成了供應鏈的脆弱性。溫控物流對於維持磷脂質的穩定性至關重要。

膳食補充劑的使用已成為主流,主要由活躍的個人消費者推動,涵蓋了從老年人記憶力增強到益智補劑和壓力管理等各種需求。最終用戶主要是個人,而兩種細分市場推動了產品劑型的多樣化:一種是面向老年人、生物有效性的軟膠囊/片劑;另一種是面向注重運動表現的年輕消費者、粉末狀混合劑。

從地理上看,美國處於主導地位,透過放鬆管制和直銷管道支持複雜配方產品的創新。日本透過FFC註冊的記憶力維護產品展現出結構性需求。德國優先考慮標籤法規下的檢驗純度和植物來源。巴西致力於加強機能性食品的發展,而阿拉伯聯合大公國則專注於符合健康生活方式的高階進口保健品。

競爭格局分為兩大陣營:一是注重酵素效率和植物性原料採購的原料生產商,二是依賴臨床證據和創新遞送技術競爭的產品開發商。 L&P食品原料有限公司在亞洲地區大規模粉末原料供應方面展現出強大的實力。 Thorne公司則專注於醫療保健專業人士的研究管道。 Soft Gel Technologies公司專注於軟膠囊封裝技術,尤其致力於提高PS-DHA複合物的生物利用度。

在市場趨勢方面,Thorne於2025年5月宣布成立科學顧問委員會,旨在促進科學健康和創新。同年12月,推出了“Taia”,這是一款透過臨床研究訓練的人工智慧健康顧問,可根據其認知功能支援產品系列提供個人化的營養補充指導。

絲胺酸市場正受益於人口結構變化、植物來源成分需求成長以及監管細分等有利因素而不斷發展。市場機會主要集中在機能性食品以增強型磷脂醯絲胺酸綴合物(例如PS-DHA)和穩定粉末領域,特別是在亞太地區。然而,原料價格波動、生產流程複雜以及功效聲明不一致等挑戰也不容忽視,這使得那些具備純度控制、研發投入和遵守當地法規等專業知識的供應商更具優勢。

本報告的主要優勢:

  • 深入分析:提供對主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局:了解全球主要參與者的策略舉措,並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢:探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議:利用這些見解,在快速變化的環境中做出策略決策,並發現新的商機和收入來源。
  • 受眾廣泛:對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

它是用來做什麼的?

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

研究範圍:

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區(包括國家)分類的收入和預測評估
  • 公司概況(策略、產品、財務資訊)及主要發展動態。

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 依形式分類的絲胺酸市場

  • 介紹
  • 粉末
  • 藥片
  • 軟膠囊

第6章 依原料分類的絲胺酸市場

  • 介紹
  • 大豆
  • 向日葵
  • 高麗菜

第7章 依最終用戶分類的絲胺酸市場

  • 介紹
  • 對於個人
  • 工業應用
  • 製藥和保健品產業

8. 各地區絲胺酸市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • L&P Food Ingredient Co., Ltd
  • Integrative Therapeutics
  • Thorne
  • Nature's Way Brands
  • Metagenics
  • COFTTEK Inc
  • Laybio
  • Double Wood Supplements
  • Haihang Industry
  • Soft Gel Technologies, Inc

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061616419

Phosphatidylserine Market is projected to grow at a 5.64% CAGR, increasing from USD 289.058 million in 2025 to USD 401.651 million in 2031.

Phosphatidylserine (PS), a phospholipid integral to cell membrane function and particularly concentrated in brain tissue, has transitioned to predominantly plant-based sourcing from soy and sunflower lecithin due to historical BSE concerns eliminating animal-derived options. This shift has solidified preference for safer, sustainable alternatives, with sunflower-derived PS commanding premiums for non-GMO attributes. The market centers on cognitive support, stress modulation, and athletic recovery, manifesting in supplements (tablets, softgels, powders) and emerging functional foods/beverages.

Growth is propelled by aging global populations and heightened awareness of cognitive decline, driving demand in the supplements segment where PS is positioned for memory and thinking skill support in geriatric cohorts. Additional momentum arises from its cortisol-modulating effects, appealing to sports nutrition for post-exercise recovery and mental performance optimization among younger consumers.

Regulatory frameworks diverge significantly. In the United States, FDA Qualified Health Claims under DSHEA permit nuanced cognitive function messaging with disclaimers, fostering aggressive marketing and high-volume adoption in supplements. Conversely, EFSA's stringent review under Regulation (EC) No 1924/2006 has denied specific Article 13.1 claims, constraining explicit brain health promotion in the EU and limiting growth to general wellness positioning. Japan's Foods with Function Claims system accelerates incorporation into registered functional foods and supplements, leveraging scientific substantiation amid an aging demographic.

Raw material pricing ties directly to volatile lecithin commodities from major soybean/sunflower producers (US, Brazil, China), with enzymatic conversion costs stratifying offerings-high-purity (50%+) for premium supplements versus lower concentrations for food fortification. Sunflower PS premiums reflect clean-label demand, while supply chain vulnerabilities stem from concentrated conversion expertise in China and North America, necessitating temperature-controlled logistics for phospholipid stability.

The supplements application dominates, fueled by proactive individual consumers spanning geriatric memory support and nootropic/stress management needs. End-users are primarily individuals, with dual cohorts driving diversified formats: softgels/tablets for bioavailability in older demographics, powders for mixing in performance-oriented younger users.

Regionally, the US leads via permissive regulation and direct-to-consumer channels, supporting innovation in combination formulas. Japan exhibits structural demand through FFC-registered products targeting memory maintenance. Germany prioritizes verifiable purity and plant sourcing amid claim restrictions. Brazil leans toward functional food fortification, while the UAE focuses on premium imported supplements aligned with wellness lifestyles.

Competition bifurcates between raw ingredient producers emphasizing enzymatic efficiency and plant sourcing, and finished product formulators competing on clinical backing and delivery innovation. L&P Food Ingredient Co., Ltd. excels in large-scale Asian conversion for bulk powder supply. Thorne targets practitioner-channel supplements with research emphasis. Soft Gel Technologies, Inc. specializes in softgel encapsulation, often for PS-DHA conjugates enhancing bioavailability.

In market developments, Thorne announced the formation of a Scientific Advisory Board in May 2025 to advance scientific wellness and innovation. In December 2025, Thorne launched Taia, an AI-powered wellness advisor trained on clinical research, providing personalized supplement guidance supportive of its cognitive portfolio.

The phosphatidylserine market evolves through demographic tailwinds, plant-based imperatives, and regulatory segmentation. Opportunities center on enriched conjugates (e.g., PS-DHA) and stabilized powders for functional foods, particularly in Asia Pacific, while challenges include commodity volatility, conversion complexity, and claim disparities-favoring suppliers with purity control, research investment, and regional compliance expertise.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Phosphatidylserine Market Segmentation

  • By Form
  • Powder
  • Tablet
  • Softgels
  • By Source
  • Fish
  • Soy
  • Sunflowers
  • Cabbage
  • By End User
  • Individuals
  • Industrial Use
  • Drugs and Supplement Industry
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PHOSPHATIDYLSERINE MARKET BY FORM

  • 5.1. Introduction
  • 5.2. Powder
  • 5.3. Tablet
  • 5.4. Softgels

6. PHOSPHATIDYLSERINE MARKET BY SOURCE

  • 6.1. Introduction
  • 6.2. Fish
  • 6.3. Soy
  • 6.4. Sunflowers
  • 6.5. Cabbage

7. PHOSPHATIDYLSERINE MARKET BY END USER

  • 7.1. Introduction
  • 7.2. Individuals
  • 7.3. Industrial Use
  • 7.4. Drugs and Supplement Industry

8. PHOSPHATIDYLSERINE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. L&P Food Ingredient Co., Ltd
  • 10.2. Integrative Therapeutics
  • 10.3. Thorne
  • 10.4. Nature's Way Brands
  • 10.5. Metagenics
  • 10.6. COFTTEK Inc
  • 10.7. Laybio
  • 10.8. Double Wood Supplements
  • 10.9. Haihang Industry
  • 10.10. Soft Gel Technologies, Inc

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations